Genetic Engineering & Biotechnology News

Select all

Other
Restricted accessOtherFirst published March, 2026pp. 2-6
Pharma’s AI Investment Signals New Drug Discovery Paradigm
Fay Lin
Other
Restricted accessOtherFirst published March, 2026pp. 4-5
From the Editor in Chief
Other
Restricted accessOtherFirst published March, 2026pp. 6-7
ALS and Dementia Linked to Bacterial Sugar via Gut–Brain Axis
Other
Restricted accessOtherFirst published March, 2026pp. 8-9
Fully Continuous Bioprocessing Drops mAb Costs
Gail Dutton
Other
Restricted accessOtherFirst published March, 2026pp. 10-13
Top 10 Takeover Targets of 2026
Alex Philippidis
Other
Restricted accessOtherFirst published March, 2026pp. 14-17
Smarter Filings,Smarter Factories
Mike May
Other
Restricted accessOtherFirst published March, 2026pp. 18-20
Genome Editing for Biopharmaceutical Manufacturing
Surya KarunakaranFerenc Boldog
Other
Restricted accessOtherFirst published March, 2026pp. 26-29
AgBio Redesigning Tomorrow’s Crops
Kathy Liszewski
Other
Restricted accessOtherFirst published March, 2026pp. 30-33
In Vivo CAR T Therapy Will the Bets Pay Off?
MaryAnn Labant
Other
Restricted accessOtherFirst published March, 2026pp. 34-37
Expanding the Druggable Proteome with Tech Advances
Tiffany Yesavage
Other
Restricted accessOtherFirst published March, 2026pp. 38-41
Standouts among Non-CHO Cell Expression Systems
Gail Dutton
Other
Restricted accessOtherFirst published March, 2026pp. 42-43
People
Other
Restricted accessOtherFirst published March, 2026pp. 44-45
Products To Watch

Volume 46, Issue 3, March 2026